Department Of Health
January 13
13:00
2025
class="gem-c-govspeak govuk-govspeak gem-c-govspeak--direction-ltr govuk-!-margin-bottom-0">
The voluntary scheme for branded medicines pricing, access and growth (VPAG) is a non-contractual voluntary agreement between the government (constituted of the Department of Health and Social Care, NHS England and the governments of Scotland, Wales and Northern Ireland) and the Association of the British Pharmaceutical Industry (ABPI), the representative body of the UK pharmaceutical industry.
VPAGaims to:
- promote better patient outcomes and a healthier population
- support UK economic growth
- contribute to a financially sustainable NHS
Operational review meetings are held every 6 months.